Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment

Cancer Letters

Volumn 309, Issue 1, 2011, Pages 85-94

  Hao, Hua ^a   Liu, Miao ^a   Wu, Ping ^a   Cai, Lei ^a   Tang, Ke ^a   Yi, Pan ^a   Li, Yongsheng ^a,b   Chen, Ying ^c   Ye, Duyun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF AIZU   (Japan)

Author keywords

C23; Hepatocarcinoma; Lipoxin; NF B; Nucleostemin

Indexed keywords

ANTINEOPLASTIC AGENT; BML 111; LIPOPOLYSACCHARIDE; LIPOXIN A; NUCLEAR PROTEIN; NUCLEOSTEMIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; HEPTANOIC ACIDS; HUMANS; LIPOXINS; LIVER NEOPLASMS; MACROPHAGES; MALE; MICE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MICROENVIRONMENT;

MUS;

EID: 79959816656     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.05.020     Document Type: Article

References (32)

1. Bingle L., Brown N.J., Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 2002, 196:254-265.
2. Lin E.Y., Nguyen A.V., Russell R.G., Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 2001, 193:727-740.
3. Lin E.Y., Li J.F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D.A., Qian H., Xue X.N., Pollard J.W. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006, 66:11238-11246.
4. Rahman M.A., Dhar D.K., Masunaga R., Yamanoi A., Kohno H., Nagasue N. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines. Cancer Res. 2000, 60:2085-2089.
5. Morris T., Stables M., Gilroy D.W. New perspectives on aspirin and the endogenous control of acute inflammatory resolution. Sci. World J. 2006, 6:1048-1065.
6. Chen Y., Hao H., He S., Cai L., Li Y., Hu S., Ye D., Hoidal J., Wu P., Chen X. Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Mol. Cancer Ther. 2010, 9:2164-2174.
7. Leite D.F., Echevarria-Lima J., Calixto J.B., Rumjanek V.M. Multidrug resistance related protein (ABCC1) and its role on nitrite production by the murine macrophage cell line RAW 264.7. Biochem. Pharmacol. 2007, 73:665-674.
8. Van de Velde S., Nguyen H.A., Van Bambeke F., Tulkens P.M., Grellet J., Dubois V., Quentin C., Saux M.C. Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes. J. Antimicrob. Chemother. 2008, 62:518-521.
9. Li Y.S., Wu P., Zhou X.Y., Chen J.G., Cai L., Wang F., Xu L.M., Zhang X.L., Chen Y., Liu S.J., Huang Y.P., Ye D.Y. Formyl-peptide receptor like 1: a potent mediator of the Ca2+ release-activated Ca2+ current ICRAC. Arch. Biochem. Biophys. 2008, 478:110-118.
10. Srivastava M., Pollard H.B. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J. 1999, 13:1911-1922.
11. Galande S. Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer. Curr. Cancer Drug Targets 2002, 2:157-190.
12. Romanova L., Kellner S., Katoku-Kikyo N., Kikyo N. Novel role of nucleostemin in the maintenance of nucleolar architecture and integrity of small nucleolar ribonucleoproteins and the telomerase complex. J. Biol. Chem. 2009, 284:26685-26694.
13. Balkwill F., Coussens L.M. Cancer: an inflammatory link. Nature 2004, 431:405-406.
14. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
15. Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 2003, 25:17-24.
16. Hagemann T., Wilson J., Kulbe H., Li N.F., Leinster D.A., Charles K., Klemm F., Pukrop T., Binder C., Balkwill F.R. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J. Immunol. 2005, 175:1197-1205.
17. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
18. Liu S., Wu P., Ye D., Huang Y., Zhou X., Li Y., Cai L. Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells. Pharmacology 2009, 84:17-23.
19. Zhou X.Y., Li Y.S., Wu P., Wang H.M., Cai Z.Y., Xu F.Y., Ye D.Y. Lipoxin A(4) inhibited hepatocyte growth factor-induced invasion of human hepatoma cells. Hepatol. Res. 2009, 39:921-930.
20. Lewis C.E., Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006, 66:605-612.
21. Lin C.Y., Lin C.J., Chen K.H., Wu J.C., Huang S.H., Wang S.M. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction. FEBS Lett. 2006, 580:3042-3050.
22. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
23. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., Kagnoff M.F., Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118:285-296.
24. Calorini L., Bianchini F., Mannini A., Mugnai G., Ruggieri S. Inhibition of lipoxygenase pathway in macrophages co-cultivated with tumor cells. Cancer Lett 2005, 223:151-158.
25. Tsai R.Y., McKay R.D. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev. 2002, 16:2991-3003.
26. Liu S.J., Cai Z.W., Liu Y.J., Dong M.Y., Sun L.Q., Hu G.F., Wei Y.Y., Lao W.D. Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies. World J. Gastroenterol. 2004, 10:1246-1249.
27. Storck S., Shukla M., Dimitrov S., Bouvet P. Functions of the histone chaperone nucleolin in diseases. Subcell Biochem. 2007, 41:125-144.
28. Semenkovich C.F., Ostlund R.E., Olson M.O., Yang J.W. A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry 1990, 29:9708-9713.
29. Christian S., Pilch J., Akerman M.E., Porkka K., Laakkonen P., Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J. Cell. Biol. 2003, 163:871-878.
30. Chen J.J., Lin Y.C., Yao P.L., Yuan A., Chen H.Y., Shun C.T., Tsai M.F., Chen C.H., Yang P.C. Tumor-associated macrophages: the double-edged sword in cancer progression. J. Clin. Oncol. 2005, 23:953-964.
31. Balkwill F., Charles K.A., Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005, 7:211-217.
32. Karin M., Lawrence T., Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124:823-835.